Gloria H Y Lau

发表

HIV-1 entry inhibition by small-molecule CCR5 antagonists: a combined molecular modeling and mutant study using a high-throughput assay.

D. Schols, Gang Chen, R. Wong, 2011, Virology.

The development of an europium-GTP assay to quantitate chemokine antagonist interactions for CXCR4 and CCR5.

S. Fricker, J. Labrecque, Gloria H Y Lau, 2005, Assay and drug development technologies.

The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitor.

D. Schols, R. Wong, S. Fricker, 2012, Biochemical pharmacology.

Metal compounds for the treatment of parasitic diseases.

J. McKerrow, R. Wong, S. Fricker, 2008, Journal of inorganic biochemistry.

Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4.

M. Ruzek, R. Wong, S. Fricker, 2009, Biochemical pharmacology.

Design and synthesis of pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication.

D. Schols, S. Fricker, G. Bridger, 2011, Bioorganic & medicinal chemistry letters.

Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4.

R. Wong, S. Fricker, L. Qin, 2006, Biochemical pharmacology.

Specificity for a CCR5 Inhibitor Is Conferred by a Single Amino Acid Residue

S. Fricker, M. Metz, Roy Vaz, 2015, The Journal of Biological Chemistry.

Characterization of a Nucleotide-Binding Domain Associated with Neisserial Iron Transport

R. MacGillivray, M. Murphy, Gloria H Y Lau, 2004, Journal of bacteriology.

Prospective CCR5 small molecule antagonist compound design using a combined mutagenesis/modeling approach.

D. Schols, S. Fricker, G. Bridger, 2011, Journal of the American Chemical Society.

Specificity of the synergistic anion for iron binding by ferric binding protein from Neisseria gonorrhoeae.

M. Murphy, C. Haynes, M. Tanokura, 2004, Biochemistry.